Actimis Pharmaceuticals is a biopharmaceutical company focused on the development of small molecule therapeutics for respiratory problems.
Business Model:
Revenue: $0
Employees: 11-50
Actimis was acquired by
Boehringer Ingelheim.
The acquisition happend on 2008-06-17.
Details of the transaction were not public
Address: 10835 Road To the Cure
City: San Diego
State: CA
Zip: 92121
Country: US
Actimis Pharmaceuticals is a biopharmaceutical company focused on the development of small molecule therapeutics for respiratory problems.
Contact Phone:
+18584581890
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2005 | Series A | 2 | $6M |
Mitsui Global Investment Sanderling Ventures Mitsui Global Investment Sanderling Ventures |
4/2005 | Series B | $9.6M |
Sanderling Ventures Mitsui Ventures |
6/2005 | Series A | $6M |
Sanderling Ventures Mitsui Ventures |
6/2008 | Venture Round | 1 | $9.6M |
Sanderling Ventures Sanderling Ventures |
3/2017 | Debt | $452k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|